JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A1404 Rigosertib sodium salt

1 Citation

Target: PLK

Summary: Plk1 inhibitor

≥23.65 mg/mL
A1186 AMG-208

Summary: C-Met inhibitor,potent and highly selective

insoluble in EtOH; insoluble in H2O; ≥3.83 mg/mL
A2806 BX-912

Summary: PDK1 inhibitor,potent and ATP-competitive

≥23.55 mg/mL
A1718 Posaconazole

Target: Cytochrome P450 (CYP450)|sterol demethylase

Summary: Sterol C14ɑ demethylase inhibitor

≥35.04 mg/mL
A2415 Acitretin

Target: RARs

Summary: Metabolite of etretinate

insoluble in EtOH; insoluble in H2O; ≥16.32 mg/mL
A1987 Ki16425

6 Citation

Target: LPA Receptors

Summary: LPA receptor antagonist

≥23.75 mg/mL
A1352 Zoledronic Acid

1 Citation

Target: Farnesyl Diphosphate Synthases

Summary: Potent nitrogen-containing bisphosphonates

insoluble in DMSO; insoluble in H2O; insoluble in EtOH
A1778 Vatalanib (PTK787) 2HCl

Target: VEGFR

Summary: Tyrosine kinase receptor inhibitor

≥21 mg/mL
A5926 Febuxostat

Summary: non-purine selective inhibitor of xanthine oxidase

insoluble in H2O; ≥15.55 mg/mL
A5755 MK-1775

4 Citation

Summary: Wee1 kinase inhibtor,potent and ATP-competitive

≥25.03 mg/mL